Japan became first country to approve Regeneron antibody cocktail (casirivimab and imdevimab) for treatment of COVID-19
On Jul. 20, 2021, Regeneron announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) had approved Regeneron’s…
On Jul. 20, 2021, Regeneron announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) had approved Regeneron’s…
On Jul. 16, 2021, Merck announced the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCE (Pneumococcal 15-valent…
On Jul. 16, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jul. 16, 2021, the Centers for Disease Control and Prevention (CDC) annouced and the Texas Department of…
On Jul. 15, 2021, Corvus Pharmaceuticals announced that it had discontinued its Phase 3 study of mupadolimab for…
On Jul. 15, 2021, iBio announced that preclinical studies of IBIO-202, its subunit vaccine candidate that targets the…
On Jul. 14, 2021, Hologic announced that it had obtained a CE Mark for the use of saliva…
On Jul. 13, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, and Quantum Leap Healthcare Collaborativeル…
On Jul. 13, 2021, the Food and Drug Administration (FDA) revisions to the vaccine recipient and vaccination provider…
On Jul. 12, 2021, Moderna announced a supply agreement with the government of Argentina for 20 million doses…
On Jul. 12, 2021, BioNTech announced that Fosun Industrial Co. had reached advance procurement agreements for the mRNA-based…
On Jul. 12, 2021, Gavi, the Vaccine Alliance, announced that it had signed advance purchase agreements with Sinopharm…
On Jul. 9, 2021, Humanigen announced its submission for Marketing Authorization for lenzilumab in COVID-19, begun in Jun….
On Jul. 9, 2021, a federal jury convicted a timber thief who authorities said started a large forest…
On Jul. 9, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Ortho-Clinical…
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
On Jul. 8, 2021, access to the worldメs largest browsable resource linking rare protein-coding genetic variants to human…
On Jul. 8, 2021, Pfizer and BioNTech announced encouraging data in the ongoing booster trial of a third…
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…
On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…
On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…
On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyメs Investigational…
On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…
On Jun. 30, 2021, CureVac announced results from the final analysis of its 40,000 subject international pivotal Phase…